Facebook link Linked In link You Tube link

Career Opportunities

From academia to government to industry; below are the openings available in the immunology job market! Click on each job posting to find out more details:

Post-doctoral Fellow - Systemic Autoimmunity Pathogenesis in American Indians (JJames)
Oklahoma Medical Research Foundation

Tenure-Track Faculty Position

Department of Pathology and Laboratory Medicine
David Geffen School of Medicine – UCLA

Assistant/Associate Faculty Position
Benaroya Research Institute

Postdoctoral Fellowship Position
The Feinstein Institute for Medical Research

Biomedical/Scientific Writing Post-doctoral Fellow – ACI (JJames)
Oklahoma Medical Research Foundation (OMRF)

Senior Post-doctoral Fellow in Systemic Autoimmunity (JJames)
Oklahoma Medical Research Foundation (OMRF)

Senior Post-doctoral Fellow/Post-doctoral Fellow (JJames) – Anthrax/Influenza Vaccination Response
Oklahoma Medical Research Foundation (OMRF)

Assistant/Associate Staff Scientist – Systemic Autoimmunity – (JJames)
Oklahoma Medical Research Foundation (OMRF)

Assistant/Associate Staff Scientist (JJames) – Anthrax/Influenza Vaccination Response
Oklahoma Medical Research Foundation (OMRF)


Remember to visit the FOCIS Grants/Awards site regularly to view new grant opportunities in the field of clinical immunology and related disciplines. Grants are currently listed from the NIH Roadmap, CADE, CTOT, and more.

Related Events

Montreal Immunology Meetings (MIM)
Monday, November 24, 2014
Montreal, Canada

American Uveitis Society 19th Annual Winter Symposium
January 17-19, 2015
Park City, Utah, USA

Advanced Course in Basic & Clinical Immunology
February 8-12, 2015
Hotel Valley Ho Scottsdale, Arizona, USA

2015 BMT Tandem Meetings
February 11-15, 2015
San Diego, California, USA

Innate Immune Memory
March 18-20, 2015
Hinxton, Cambridge, United Kingdom

Immunology of Diabetes Society 14th International Congress
April 12-16, 2015
Munich, Germany

American Rhinologic Society at COSM
April 23-24, 2015
Boston, Massachusetts, USA

74th Annual Meeting of the Society for Investigative Dermatology
May 6-9, 2015
Atlanta, Georgia, USA

Basic Immunology in Medicine: Update 2015
Tuesday, June 23, 2015
Hilton San Diego Bayfront
San Diego, California

Computational Immunology
Tuesday, June 23, 2015
Hilton San Diego Bayfront
San Diego, California, USA

Interventional Immunology
Wednesday, June 24, 2015
Hilton San Diego Bayfront
San Diego, California, USA

Clincial Trials for Immunologic Disease
Wednesday, June 24, 2015
Hilton San Diego Bayfront
San Diego, California, USA

FOCIS 2015
June 24-27, 2015
Hilton San Diego Bayfront
San Diego, California, USA

17th International Congress of Mucosal Immunology (ICMI)
July 14-18, 2015
Berlin, Germany

2015 American Rhinologic Society Summer Sinus Symposium
July 17-18, 2015
Chicago, Illinois, USA

Association of Medical Laboratory Immunologists 28th Annual Meeting
August 14-17, 2015
New Orleans, LA, USA

Entrepreneurs in Clinical Academica (ECA)
September 21-25, 2015
Fontainebleau, France

41st Annual Meeting of the American Society for Histocompatibility and Immunogentics
September 28-October 2, 2015
Savannah, Georgia, USA

Basic Immunology In Medicine: Update 2016
Tuesday, June 21, 2016
Seaport & World Trade Center
Boston, Massachusetts, USA

Interventional Immunology
Wednesday, June 22, 2016
Seaport & World Trade Center
Boston, Massachusetts, USA

FOCIS 2016
June 22-25, 2016
Seaport Hotel & World Trade Center
Boston, Massachusetts, USA

Interested in more Related Meetings? Click on the Events/Meetings tab on the FOCIS page.

FOCIS Centers of Excellence Trainee Satellite Symposium Celebrates its 11th Year of Developing Future Leaders

FOCIS Centers of Excellence Trainee Satellite Symposium LogoThe FOCIS Centers of Excellence (FCE) is a network of 70 FOCIS- designated medical centers. These centers are some of the best in the world and through the FCE network; they combine their expertise, patient populations and data for research, grants, and other collaborative ventures. A main focus of these centers is training, and each year the centers are given the opportunity to send two trainees to participate in the Trainee Satellite Symposium (TSS), held the first day of the FOCIS Annual Meeting.

This year's TSS was chaired by Timothy Niewold, MD, FCE Chair, Mayo Clinic and Matthew Albert, MD, PhD, FCE Multinational Chair, Institut Pasteur and welcomed 57 trainees from 37 centers. Abstracts were submitted and 10 were selected to give oral presentations at the symposium and the others were presented in a poster tour format following the symposium. The symposium also featured invited lecturers Muzlifah Haniffa, MD, Newcastle University; Jorge Kalil, MD, PhD, University of Sao Paulo and Jordan Pober, MD, PhD, Yale University.

TSS gives trainees the opportunity to hone their presentation skills among colleagues and benefit from the mentorship of FCE Directors who are present through the day. The oral presenters were assigned a mentor that they communicated with preceding the symposium and received a critique of their presentation afterwards. The poster tours were led by FCE Directors and the trainees gave a five minute presentation of their work with and have the opportunity for group discussion and questions. Two posters were selected as Posters of Distinction and were given an award at the Annual Meeting Opening Reception. Congratulations to this year's Poster of Distinction winners Esther Zaumaquero Martinez and Alejandra Urrutia!

Want to participate? Tell your FCE Director to submit your name by January 27, 2015. Receive $500 reimbursement and complimentary meeting registration!

FOCIS Centers of Excellence Spotlight:

FOCIS Congratulates Yale as an Outstanding FOCIS Center of Excellence in their $14.5 million Collaboration with AbbVie

rsz 2jordan pober
Yale FCE Director, Jordan Pober, MD, PhD

With the goal of advancing the understanding of the autoimmune and inflammatory diseases, and trying to find new and better treatments, Yale School of Medicine (YSM) has entered into a research partnership with the global pharmaceutical company AbbVie. Formed in 2013 when Abbott Laboratories divided into two companies, this North Chicago, Illinois based company will provide

Catalyzed by Yale's preeminence in immunobiology research, the partnership marks another milestone in the formation of academia-industry partnerships at Yale. "This is a collaboration between an industry leader in the treatment in autoimmune diseases and one of the best academic immunology research programs," says Richard A Flavell, Ph.D., Chair and Sterling Professor of Immunobiology and a Howard Hughes Medical Institute Investigator. "Our shared goal is the development of better treatments for immunologic diseases."$14.5 million over a five-year period to fund research led by the Yale faculty.

The AbbVie-Yale Collaboration in Immunobiology will be headed by a five-member joint steering committee. Members from Yale are Flavell; Jordan S. Pober, MD, Bayer of Professor of Translational Medicine, Professor of Dermatology and Pathology, and director of the Department of Immunobiology's Human and Translational Immunology Program; and Akiko Iwasaki, PhD, Professor of Immunobiology and of Molecular, Cellular, and Developmental Biology, and Howard Hughes Medical Institute investigator. Members of AbbVie are Lisa M. Olson, PhD, vice president of immunology, and Hamish Allen, PhD,Director of AbbVie's global external research in immunology.

Since the founding of the immunobiology program at Yale in 1988, it has become a world leader in basic immunology research. The key breakthroughs made were the components of the innate immune system called toll-like receptors (TLRs) prompt expression of the genes that provide the adaptive immune system with necessary advance intelligence to do its job. The study of TLRs is now one of the most active and important research in areas of immunobiology.

AbbVie, in turn, is known not only for its pharmaceutical research and drug discovery capabilities, but also for its array of specialized strengths. Thus collaboration will give Yale researchers access to proprietary AbbVie molecules known as dual-variable domain antibodies, which combine two targets, making them valuable experimental and treatment tools.

The $14.5 million in funding is available to School of Medicine faculty with primary or secondary appointments in the Department of Immunobiology. Six of the 14 grants will be four-year "full research" grants of $1 million each, and eight will be two-year pilot project grants of $160,000 each, to supply early-stage research.

The collaboration is part of a longstanding relationship that Flavell built with Abbott Laboratories in the 1990's. Flavell helped guide Abbott's acquisition of a research facility in Worcester, Massachusetts, two hours from Yale. Dr. Olson said, "The proximity allows for close interactions between AbbVie and Yale Scientists, which will greatly advance a deep understanding of the biology around potential new therapeutics."